Key Financial Data Of Reporting Company

Fuji Pharma Co.,Ltd. - Filing #7730783

Concept 2016-10-01 to
2017-09-30
2016-10-01 to
2017-09-30
As at
2017-09-30
As at
2017-09-30
As at
2016-09-30
2015-10-01 to
2016-09-30
2015-10-01 to
2016-09-30
As at
2016-09-30
As at
2015-09-30
As at
2015-09-30
2014-10-01 to
2015-09-30
2014-10-01 to
2015-09-30
2013-10-01 to
2014-09-30
2013-10-01 to
2014-09-30
As at
2014-09-30
As at
2014-09-30
2012-10-01 to
2013-09-30
As at
2013-09-30
2012-10-01 to
2013-09-30
As at
2013-09-30
Key financial data of reporting company
Business results of reporting company
Net sales
32,986,000,000 JPY
35,387,000,000 JPY
31,993,000,000 JPY
34,229,000,000 JPY
29,490,000,000 JPY
31,680,000,000 JPY
27,397,000,000 JPY
29,215,000,000 JPY
25,174,000,000 JPY
23,948,000,000 JPY
Ordinary profit (loss)
4,478,000,000 JPY
4,628,000,000 JPY
3,215,000,000 JPY
3,251,000,000 JPY
3,185,000,000 JPY
3,099,000,000 JPY
3,305,000,000 JPY
3,198,000,000 JPY
3,376,000,000 JPY
3,544,000,000 JPY
Profit (loss)
3,235,000,000 JPY
2,146,000,000 JPY
2,267,000,000 JPY
2,180,000,000 JPY
2,242,000,000 JPY
Equity in earnings (losses) of affiliates if equity method is applied
JPY
JPY
JPY
JPY
JPY
Share capital
3,799,000,000 JPY
3,799,000,000 JPY
3,799,000,000 JPY
3,799,000,000 JPY
2,447,000,000 JPY
Total number of issued shares
15,626,900 xbrli:shares
15,626,900 xbrli:shares
15,626,900 xbrli:shares
15,626,900 xbrli:shares
14,120,000 xbrli:shares
Net assets
32,485,000,000 JPY
32,601,000,000 JPY
29,226,000,000 JPY
29,836,000,000 JPY
28,458,000,000 JPY
28,593,000,000 JPY
28,118,000,000 JPY
28,544,000,000 JPY
24,066,000,000 JPY
23,874,000,000 JPY
Total assets
48,155,000,000 JPY
49,551,000,000 JPY
48,147,000,000 JPY
47,557,000,000 JPY
44,479,000,000 JPY
45,773,000,000 JPY
46,237,000,000 JPY
49,027,000,000 JPY
39,138,000,000 JPY
37,259,000,000 JPY
Net assets per share
2,170.81
2,178.46
1,953.65
1,994.54
1,903.30
1,912.27
1,799.37
1,826.54
1,704.46
1,690.87
Dividend paid per share
48.00
45.00
44.00
44.00
40.00
Interim dividend paid per share
23.00
21.00
20.00
20.00
18.00
Basic earnings (loss) per share
216.19
220.63
143.51
141.64
149.06
137.55
147.38
140.53
146.48
158.81
Diluted earnings per share
Equity-to-asset ratio
0.675 xbrli:pure
0.658 xbrli:pure
0.607 xbrli:pure
0.627 xbrli:pure
0.640 xbrli:pure
0.625 xbrli:pure
0.608 xbrli:pure
0.582 xbrli:pure
0.615 xbrli:pure
0.641 xbrli:pure
Rate of return on equity
0.104 xbrli:pure
0.107 xbrli:pure
0.074 xbrli:pure
0.073 xbrli:pure
0.080 xbrli:pure
0.073 xbrli:pure
0.084 xbrli:pure
0.079 xbrli:pure
0.086 xbrli:pure
0.098 xbrli:pure
Price-earnings ratio
17.76 xbrli:pure
17.40 xbrli:pure
18.68 xbrli:pure
18.93 xbrli:pure
13.43 xbrli:pure
14.55 xbrli:pure
13.78 xbrli:pure
14.45 xbrli:pure
11.86 xbrli:pure
10.94 xbrli:pure
Payout ratio
0.222 xbrli:pure
0.314 xbrli:pure
0.295 xbrli:pure
0.299 xbrli:pure
0.252 xbrli:pure
Net cash provided by (used in) operating activities
3,238,000,000 JPY
4,509,000,000 JPY
589,000,000 JPY
2,757,000,000 JPY
3,630,000,000 JPY
Net cash provided by (used in) investing activities
-1,534,000,000 JPY
-3,319,000,000 JPY
999,000,000 JPY
-1,975,000,000 JPY
-6,601,000,000 JPY
Net cash provided by (used in) financing activities
-3,042,000,000 JPY
78,000,000 JPY
-4,635,000,000 JPY
1,293,000,000 JPY
3,743,000,000 JPY
Cash and cash equivalents
5,503,000,000 JPY
6,815,000,000 JPY
5,664,000,000 JPY
8,680,000,000 JPY
6,521,000,000 JPY
Number of employees
717 xbrli:pure
1,480 xbrli:pure
1,455 xbrli:pure
691 xbrli:pure
695 xbrli:pure
1,469 xbrli:pure
681 xbrli:pure
1,467 xbrli:pure
1,450 xbrli:pure
619 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.